Lamotrigine Tablet, Extended Release
Product Images NDC 70518-1153

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70518-1153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine 50mg 70518 1153 01

Lamotrigine 50 mg extended-release tablets packaging label, showing quantity of 50 tablets per box. The label includes the NDC 70518-1153-01 and indicates repackaging by RemedyRepack Inc. It also displays storage instructions and manufacturer information for Torrent Pharma Inc., Basking Ridge, NJ.*

FDA Label Image

Remedy_label (Remedy Label)

Lamotrigine 50 mg extended-release tablet packaging label showing a quantity of 1 tablet. The label includes the NDC number 70518-1153-02, repackaged by RemedyRepack Inc. in Indiana, PA, with storage instructions and manufacturer information for Torrent Pharma Inc. in New Jersey.*

FDA Label Image

Image Clinicalstudy1 Partialonsetseizure

A cumulative responder rate chart showing percent of patients on the horizontal axis and responder rate (equal or greater improvement versus worsening) on the vertical axis. It compares Lamotrigine Extended-Release Tablets (N=70) to placebo (N=73) using solid and dashed lines respectively, illustrating patient response rates across treatment groups.*

FDA Label Image

Image Clinicalstudy2 Partialonsetseizure

A responder rate curve graph comparing Lamotrigine Extended-Release Tablets and placebo. The x-axis shows percent of patients from 100 to 0, and the y-axis shows responder rate ranging from worsening (-100%) to improvement (100%). Two curves represent placebo and Lamotrigine ER tablets, illustrating differences in patient response rates.*

FDA Label Image

Structure

Chemical structure of lamotrigine showing its molecular framework including chlorine atoms, amino groups, and a triazine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.